The biopharmaceutical industry is growing rapidly as a result of significant advancements in biotechnology and drug ...

The announcement by AstroZeneca follows a growing trend of companies pledging to invest in pharmaceutical manufacturing on ...

On July 21, AstraZeneca said it would invest $50 billion in U.S. production by 2030. At the core is a manufacturing plant to go somewhere in Virginia.

AstraZeneca said the mammoth investment will create tens of thousands of jobs across the US, “powering growth and delivering next-generation medicines for patients in America and worldwide”.

WASHINGTON (Reuters) -AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on Monday, the latest big investment by a pharmaceutical ...

AstraZeneca said it plans to invest $50 billion in the U.S. by 2030, marking the latest drugmaker to commit to American manufacturing as looming tariffs threaten to raise costs across the industry.

'Queen Charlotte: A Bridgerton Story' breakout Corey Mylchreest charms Sofia Carson's Anna in the trailer for 'My Oxford Year' coming to Netflix.

Former Oxford University professor Newton Howard is fueled by his fascination with quantum biology and neuroscience. He believes there is a future where we can not only understand the brain at a ...

AstraZeneca PLC ADR Annual stock financials by MarketWatch. View the latest AZNA financial statements, income statements and financial ratios.

Pharmaceutical company AstraZeneca has cancelled a planned 450 million-pound investment in a vaccine manufacturing plant in northwest England.

AstraZeneca announced that this week it has received two positive recommendations from the National Institute for Health and Care Excellence (NICE) for the treatment of lung cancer patients across ...

AstraZeneca (AZN) stated: “Leon Wang, Executive Vice President International and AstraZeneca China President, is cooperating with an ongoing investigation by Chinese authorities.